Read + Share
Theivanthiran B, Evans KS, DeVito NC, Plebanek M, et al. A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to
anti-PD-1 immunotherapy. J Clin Invest 2020;130:2570-2586.
PMID: 32017708
|
 |
|
Theivanthiran B, Evans KS, DeVito NC, Plebanek M, et al. A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to
anti-PD-1 immunotherapy. J Clin Invest 2020;130:2570-2586.
PMID: 32017708
|
|
|
|